The Male Infertility Market to grow at an exponential substantiation
The Male Infertility Market, in the next 10 years, is expected to substantiate. Hospital decision support solutions are being floated, and the status quo is expected to stay the same even going forward. Herein, value propositions are made to the society on the whole and patients in particular by the government, private insurance companies, and social security organizations working in unison. As such, the healthcare industry is expected to witness a good number of clinical outcomes in the forthcoming period.
Male fertility is the male’s inability to cause pregnancy in a fertile
women. Infertility in men are due to deficiencies in sperm formation,
concentration or transportation. Various disorders such as physical problems,
psychological problems, hormonal disturbances, causes male infertility.
Though many treatment options are available, but somehow in most of the cases treatment
don’t work.
In some cases male infertility is caused due to testicular damage leading to
inability of testicle to produce sperm. The damaged testicle usually is unable
to regain its sperm-making capability and this trait of male infertility is
analogous to menopause (though not natural like menopause) which cannot usually
be treated. Despite limited ability of medicines to treat male
infertility, many successful treatment options are available for many causes.
Some of the factors responsible for growth of male infertility market are
changing lifestyle, increasing ages, excess consumption of alcohol and drugs,
environmental factors and genetic abnormalities. Moreover, technological
advancements are bridging the gap and the spending capacity of individuals has
also increased.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/14713
However, demand for male infertility treatment is increasing as there is
increasing awareness among the people about their health problems and they are
willing to overcoming the social taboo and accepting the fact of male
infertility and turning towards the treatment options.
But the high cost of treatment is a major hurdle to most of the people in
need for this treatment. Also, the number of repeated treatment failures leads
to emotional impact on the patient compelling the patient to opt out of the
treatment which is also another limiting factors of male infertility treatment.
Male Infertility Market: Segmentation
|
On the basis of symptoms |
|
|
On the
basis of technique |
|
|
On the
basis of end-user |
|
Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com
Approximately 20% of couples attempting for first pregnancy meet with
failures. Authorities define these patients as primarily infertile if they have
been unable to achieve a pregnancy after one year of unprotected intercourse.
Data available over the past decade reveal that around 35% of cases pathology
is found in the man alone, and in another 25% both the man and woman are
abnormal.
Therefore, the male factor is at least partly responsible in about 50% of
infertile couples. According to National Institutes of Health in the U.S. there
are approximately 1.5 million infertile couples of which about 35% accounts to
male infertility.
There is a steady increase in the global infertility rates both in the
developed and developing nations. The changing life style, delayed pregnancy
and aging are few of the factors driving the global infertility market in
males.
Regionally, the market can be segmented into North America, Europe, Asia
Pacific, Latin America and Middle East and Africa. North America dominates the
male infertility market due to factors like, increasing cases of male
infertility due to life style factors such as obesity and diet, technological
advancements which is fulfilling the need of treatment. Increasing cases of
medical tourism and homosexuality in the U.S. is also boosting the male
infertility market.
Following North America is Europe owing to encouraging healthcare
infrastructure and high healthcare expenditure in this region is the driving
factors for male infertility market in this region. Asia Pacific is expected to
be a significant market due to the rising infertility cases and awareness about
infertility treatments and introduction of newer techniques in the treatment
such as DNA fragmentation and computer assisted semen
analysis.
Government is also encouraging the adoption of the technological
advancements but the private and public insurance plans rarely pay for
infertility treatments which limits the lower income people to go for the
treatment in this region.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/14713
Some of the major market players of male infertility market include Access
Pharmaceuticals, Inc., Andrology Solutions, ASKA Pharmaceutical Co. Ltd, Cordex
Pharma, Inc., EMD Serona Inc., Halotech DNA SL, Intas Pharmaceuticals Ltd.,
Pantarhei Bioscience B, SCSA Diagnostics, and Zydus Cadila Healthcare Limited.
Rising incidences of male infertility, increasing healthcare expenditure,
development of healthcare infrastructure and urge of having a baby leads to
increase in adoption rate of the cutting age treatments leading to rise of the
male infertility market.
About Us: - Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
Comments
Post a Comment